Influence ofhigh flux dialysis on homocysteine levels and major cardiovascular events
10.3969/j.issn.1006-5725.2017.10.003
- VernacularTitle:高通量透析对同型半胱氨酸水平及主要心血管事件的影响
- Author:
Aizhen HOU
;
Guanqing XIAO
;
Yu ZHANG
;
Yaozhong KONG
- Keywords:
Uremia;
Homocysteine;
High flux hemodialysis;
Cardiovascular disease
- From:
The Journal of Practical Medicine
2017;33(10):1544-1547
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the influence of highflux hemodialysis(HFD)on homocysteine(Hcy) level and major cardiovascular events of maintenance hemodialysis (MHD) patients. Methods Patients eligible for inclusion were randomly divided into HFD group and low flux hemodialysis(HD)group with 30 cases in each group. Patient′s serum homocysteine (Hcy),major cardiovascular events and various clinical indicators were observed for 12 months then the data were analyzed. Results Hcy baseline levels in 2 groups(21.02 ± 11.79 mmol/L vs. 19.86 ± 6.97 mmol/L)indicated no significant difference(P = 0.162)before hemodialysis but Hcy levels had significant difference(20.29 ± 11.45 mmol/L vs. 24.57 ± 13.23 mmol/L),(P=0.045)after 12-month observation. There was lower incidence of major cardiovascular events in HFD when compared to that in HD group (10.0% vs. 33.3%) which showed significantly statistical difference (P=0.034),and there was no mortality in HFD group but 1 case of death in HD group. All-cause mortality in 2 groups showed no significant difference (P > 0.05). Conclusion Long-term HFD treatment significantly reduces Hcy levels and the incidence of major cardiovascular events of MHD patients
